Tags

Type your tag names separated by a space and hit enter

[Candidate patient for treatment with continuous apomorphine infusion].
Rev Neurol. 2012; 55 Suppl 1:S15-9.RN

Abstract

Subcutaneous apomorphine infusion has been shown to be effective in reducing motor fluctuations and, to a lesser extent, also the levodopa induced dyskinesias in patients with advanced Parkinson's disease (PD). Based on the literature data, the following article reviews the clinical features of PD patients in order to be considered candidates for this therapy. In general, the vast majority of patients with advanced PD can benefit from this therapy and the authors' experience suggests that it should be considered as soon as the conventional pharmacological therapy fails to significantly reduce the number of daily off hours.

Authors+Show Affiliations

Hospital de la Santa Creu i Sant Pau, 08025 Barcelona, Espana.No affiliation info available

Pub Type(s)

Journal Article
Review

Language

spa

PubMed ID

23169228

Citation

Martí, María José, and Jaume Kulisevsky. "[Candidate Patient for Treatment With Continuous Apomorphine Infusion]." Revista De Neurologia, vol. 55 Suppl 1, 2012, pp. S15-9.
Martí MJ, Kulisevsky J. [Candidate patient for treatment with continuous apomorphine infusion]. Rev Neurol. 2012;55 Suppl 1:S15-9.
Martí, M. J., & Kulisevsky, J. (2012). [Candidate patient for treatment with continuous apomorphine infusion]. Revista De Neurologia, 55 Suppl 1, S15-9.
Martí MJ, Kulisevsky J. [Candidate Patient for Treatment With Continuous Apomorphine Infusion]. Rev Neurol. 2012;55 Suppl 1:S15-9. PubMed PMID: 23169228.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Candidate patient for treatment with continuous apomorphine infusion]. AU - Martí,María José, AU - Kulisevsky,Jaume, PY - 2012/11/22/entrez PY - 2012/10/20/pubmed PY - 2014/8/19/medline SP - S15 EP - 9 JF - Revista de neurologia JO - Rev Neurol VL - 55 Suppl 1 N2 - Subcutaneous apomorphine infusion has been shown to be effective in reducing motor fluctuations and, to a lesser extent, also the levodopa induced dyskinesias in patients with advanced Parkinson's disease (PD). Based on the literature data, the following article reviews the clinical features of PD patients in order to be considered candidates for this therapy. In general, the vast majority of patients with advanced PD can benefit from this therapy and the authors' experience suggests that it should be considered as soon as the conventional pharmacological therapy fails to significantly reduce the number of daily off hours. SN - 1576-6578 UR - https://www.unboundmedicine.com/medline/citation/23169228/[Candidate_patient_for_treatment_with_continuous_apomorphine_infusion]_ L2 - https://medlineplus.gov/parkinsonsdisease.html DB - PRIME DP - Unbound Medicine ER -